Evidence map›Paper›PMID 40596526›Full record

ArticleScientific reports2025

Nomogram prediction of overall survival in patients with bone metastases from hepatocellular carcinoma: a SEER-based retrospective cohort study.

Qingliang Song, Yilin Kong, Chuiyang Zheng, Dajin Pi, Wen Fan, Jianwei Zhen, Jinyue Pan, Lianghao Liu, Siyuan Huang, Fangyu Zhou and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qingliang Song *School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Yilin Kong *The Second Affiliated Hospital of Guangzhou, University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Chuiyang ZhengSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Dajin PiSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Wen FanSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Jianwei ZhenSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Jinyue PanSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Lianghao LiuSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Siyuan HuangSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Fangyu ZhouSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Qinhe YangSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China. tyangqh@jnu.edu.cn.
Yupei ZhangSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China. zyp6115@jnu.edu.cn.
Maoxing PanSchool of Traditional Chinese Medicine, Jinan University, Guangzhou, China. maoxingpan@jnu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to construct a nomogram for predicting overall survival in patients with bone metastases (BM) from hepatocellular carcinoma (HCC), leveraging data from the Surveillance, Epidemiology, and End Results (SEER) database spanning the period from 2010 to 2015. The patient cohort was randomly partitioned into a training set (n = 338) and a validation set (n = 145). Kaplan-Meier analysis and multivariate Cox proportional hazards regression identified marital status, liver surgery, and radiotherapy/chemotherapy as significant prognostic factors (P ≤ 0.05), which were subsequently integrated into the nomogram. The nomogram exhibited a concordance index of 0.72 (95% confidence interval: 0.70-0.75) and demonstrated robust calibration between predicted and observed survival rates. This nomogram has the potential to accurately forecast prognosis and assist clinicians in formulating appropriate treatment strategies for patients with HCC bone metastasis.

Indexed as

Bone NeoplasmsCarcinoma, HepatocellularLiver NeoplasmsNomogramsAdultAgedFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesSEER ProgramBone metastasesHepatocellular carcinomaNomogramOverall survivalRetrospective cohort study.

Identifiers

PMID40596526
PMCPMC12215474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.